Roivant Sciences (ROIV) Income After Tax (2020 - 2026)
Roivant Sciences' Profit After Tax was -$290.61 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$273.91 million a year earlier.
Powered by 
Analysis
Roivant Sciences (ROIV) Income After Tax (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Roivant Sciences' Profit After Tax was -$414.6 million through Jun 30, 2026; for FY2026 (ended Mar 31, 2026), it was -$397.91 million.
- In earlier fiscal years, Profit After Tax was -$729.76 million in FY2025, $4.55 billion in FY2024, -$889.07 million in FY2023 and -$924.12 million in FY2022.
- Quarterly Profit After Tax has moved between -$384.9 million (fiscal Q3 2023) and $5.13 billion (fiscal Q3 2024) over five years.
- Per Business Quant data, ROIV's Profit After Tax in the three fiscal quarters before Q1 2027 was $355.74 million (Q4 2026), -$313.7 million (Q3 2026) and -$166.04 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Roivant Sciences | 29.81 Bn | 13.51 Bn | 31.77 Mn | -152.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -152.97 Mn |
| Jun 30, 2026 | -290.61 Mn |
| Mar 31, 2026 | 355.74 Mn |
| Dec 31, 2025 | -313.70 Mn |
| Sep 30, 2025 | -166.04 Mn |
| Jun 30, 2025 | -273.91 Mn |
| Mar 31, 2025 | -252.38 Mn |
| Dec 31, 2024 | -208.95 Mn |
| Sep 30, 2024 | -236.84 Mn |
| Jun 30, 2024 | -31.60 Mn |
| Mar 31, 2024 | -94.96 Mn |
| Dec 31, 2023 | 5.13 Bn |
| Sep 30, 2023 | -244.64 Mn |
| Jun 30, 2023 | -327.85 Mn |
| Mar 31, 2023 | 165.53 Mn |
| Dec 31, 2022 | -384.90 Mn |
| Sep 30, 2022 | -315.92 Mn |
| Jun 30, 2022 | -353.78 Mn |
| Mar 31, 2022 | -291.31 Mn |
| Dec 31, 2021 | -306.09 Mn |
API Access
Roivant Sciences Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();